Skip to main content
HeartCited

Supplementation with selenium and coenzyme Q10 in critically ill patients.

I P Hargreaves, D Mantle
Review British journal of hospital medicine (London, England : 2005) 2019 14 인용
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'pmid\u003D31589506'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

연구 유형
review
중재
Supplementation with selenium and coenzyme Q10 in critically ill patients. selenium supplementation (various doses) with or without coenzyme Q10 co-supplementation
대조군
Placebo
효과 방향
Mixed
비뚤림 위험
Moderate

Abstract

Multiple organ dysfunction and resultant mortality in critically ill patients has been linked with impaired cellular energy supply and oxidative stress. Clinical studies supplementing selenium, on the basis of its role as a key cofactor of antioxidant enzymes, have reported variable outcomes in critically ill patients. However, the synergistic interaction between selenium and coenzyme Q10, which has essential roles in cellular energy supply and as an antioxidant, has not been considered in such studies. This article reviews the link between selenium and coenzyme Q10, and the potential role of their co-supplementation in critical illness.

Used In Evidence Reviews

Similar Papers